Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors

Phase 2

Terminated

Conditions: Optic Glioma
Astrocytoma
Pilocytic Astrocytoma
Anaplastic Astrocytoma
Glioblastoma
Glioma
Mixed Oligoastrocytoma
Mixed Glioma
Oligodendroglioma

Interventions: Device: MRI-guided laser ablation
Device: Dynamic contrast-enhanced (DCE) MRI
Drug: Doxorubicin
Device: Dynamic susceptibility contrast (DSC) MRI
Drug: Etoposide

First Posted Date: 2015-02-26

Last Posted Date: 2024-11-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 6

Registration Number: NCT02372409

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas

Phase 1

Terminated

Conditions: Glioma
Malignant Glioma

Interventions: Drug: 6-[F-18]-Fluoro-L-3,4,-dihydroxyphenylalanine
Device: PET/MRI
Procedure: Surgical resection (standard of care)

First Posted Date: 2015-02-25

Last Posted Date: 2016-11-30

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 11

Registration Number: NCT02371031

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies

Phase 2

Completed

Conditions: Squamous Cell Carcinoma, Head and Neck
Squamous Cell Carcinoma of the Head and Neck

Interventions: Drug: Mitomycin-C
Drug: Pegfilgrastim

First Posted Date: 2015-02-24

Last Posted Date: 2025-05-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 48

Registration Number: NCT02369458

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Lidocaine for Diabetic Peripheral Neuropathy

Not Applicable

Completed

Conditions: Diabetes
Peripheral Neuropathy
Pain

Interventions: Drug: lidocaine
Drug: Placebo

First Posted Date: 2015-02-16

Last Posted Date: 2019-11-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 34

Registration Number: NCT02363803

Locations: 🇺🇸
Washington University School of Medicine/Barnes Jewish Hospital, Saint Louis, Missouri, United States

Innovative Model of Patient-Centered ConTraception

Not Applicable

Completed

Conditions: Contraception
Unintended Pregnancy

Interventions: Behavioral: CHOICE Project Structured Contraceptive Counseling
Behavioral: Contraceptive Education Session
Device: Cost Support for IUDs and implants

First Posted Date: 2015-02-16

Last Posted Date: 2020-06-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1008

Registration Number: NCT02364037

Locations: 🇺🇸
Family Care Health Center Forest Park, Saint Louis, Missouri, United States
🇺🇸
Family Care Health Center Carondelet, Saint Louis, Missouri, United States
🇺🇸
Memphis Health Center, Memphis, Tennessee, United States

Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access Study

Conditions: Cancer of the Prostate

First Posted Date: 2015-02-04

Last Posted Date: 2017-01-20

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02355054

Locations: 🇺🇸
Washington University School of Medicine, Barnes-Jewish Hospital, Saint Louis, Missouri, United States

Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Phase 1

Terminated

Conditions: Cancer of Pancreas
Pancreatic Cancer
Cancer of the Pancreas
Pancreas Cancer

Interventions: Drug: Tosedostat
Drug: Capecitabine
Procedure: Fresh tissue biopsy

First Posted Date: 2015-02-02

Last Posted Date: 2019-08-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 16

Registration Number: NCT02352831

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations

Phase 2

Completed

Conditions: Solid Malignancy
Solid Tumor

Interventions: Drug: Everolimus

First Posted Date: 2015-02-02

Last Posted Date: 2018-10-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 12

Registration Number: NCT02352844

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Package of Interventions After Recovering From Moderate Acute Malnutrition

Not Applicable

Completed

Conditions: Malnutrition

Interventions: Dietary Supplement: Lipid Nutrient Supplement
Drug: Sulfadoxine-pyrimethamine
Drug: Albendazole
Drug: Zinc
Other: Insecticide-treated bednet

First Posted Date: 2015-01-30

Last Posted Date: 2016-11-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1499

Registration Number: NCT02351687

Locations: 🇲🇼
St. Louis Nutrition Project, Blantyre, Malawi

Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients

Phase 1

Completed

Conditions: Lung Transplant Infection

Interventions: Drug: Inhaled beclomethasone
Drug: Placebo

First Posted Date: 2015-01-30

Last Posted Date: 2022-03-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 16

Registration Number: NCT02351180

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy